✦ LIBER ✦

The National Cancer Data Base Report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia

✍ Scribed by Louis F. Diehl; Lucy Hynds Karnell; Herman R. Menck

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 173 KB
Volume: 86
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19991215)86:12<2684::aid-cncr13>3.0.co;2-v

No coin nor oath required. For personal study only.

✦ Synopsis

The natural history of chronic lymphocytic leukemia (CLL) is changing, although the reasons (potential changes in the disease's biology or in patterns in patient characteristics, treatment, or referral) are unclear.

METHODS.

This report uses National Cancer Data Base (NCDB) data, which reflect a hospital-based patient population from a broad spectrum of hospitals in the United States. Age, gender, race/ethnicity, income, treatment, overall survival, and relative survival were evaluated according to time period (1985-1990 and 1991-1995). Comparisons were made with U.S. population figures for 1990 and with series published over the last 70 years.

Results

. CLL comprised 22.6% of the 108,396 cases of leukemia in the data base.

The risk of developing CLL increased progressively with age and did not plateau; the average age was 69.6 years. At the time of initial diagnosis, 60.5% of patients received no treatment (this proportion increased from 58.1% to 62.7% between the 2 time periods). Overall survival was 48.2% at 5 years and 22.5% at 10 years. The 5-year relative survival was 69.5%, 72.2%, 63.1%, and 41.7% for age groups Ͻ40, 40 -59, 60 -79, and 80ϩ years, respectively; these rates indicated that CLL, and not comorbid disease, caused the greatest percentage of deaths.

CONCLUSIONS.

The risk of developing CLL increases progressively with age without plateauing and is 2.8 times higher for older men than for older women. There is an increasing trend toward no treatment at the time of initial diagnosis. Long term overall survival of CLL patients is poor. CLL is a more fatal disease among older individuals because of the disease itself, not because of comorbid conditions.

📜 SIMILAR VOLUMES

The national cancer data base report on

The national cancer data base report on race, age, and region variations in prostate cancer treatment

✍ Curtis J. Mettlin; Gerald P. Murphy; Myles P. Cunningham; Herman R. Menck 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## BACKGROUND. Patterns of care for prostate cancer patients in the United States have changed as early detection has improved. The National Cancer Data Base of the American College of Surgeons Commission on Cancer provides information about the treatment of patients in all age, race, and regional

The National Cancer Data Base Report on

The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.

✍ Curtis J. Mettlin; Gerald P. Murphy; Charles J. McDonald; Herman R. Menck 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

BACKGROUND. An increase in the proportion of prostate carcinomas diagnosed at early, potentially curable stages has led to several changes in treatment of patients with this disease. Greater use of radical prostatectomy and external beam radiation has been documented, and recent data suggest that th

The National Cancer Data Base report on

The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas : Improved survival of surgically resected patients, 1985–1996

✍ William G. Cance; Andrew K. Stewart; Herman R. Menck 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

The Commission on Cancer data from the National Cancer Data Base (NCDB) has previously reported data evaluating time trends in various cancers, including such elements as stage of disease at diagnosis, treatment, and survival for multiple tumor sites. In this report, data collected from 1985, 1986,

The National Cancer Data Base report on

The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy : Fifth edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis

✍ Scott A. Hundahl; Jerri Linn Phillips; Herman R. Menck 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

A high proportion of U.S. patients with gastric carcinoma do not receive surgical treatment. To sharpen staging criteria and facilitate comparisons with surgical series, an analysis of patients whose treatment included gastrectomy was undertaken. In addition, to evaluate the "different disease" hypo